A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
NCT06888193
This study is recruiting at 6 US sites in 5 states, according to its ClinicalTrials.gov record last updated .
Summary
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Moderate to Severe Plaque Psoriasis
- Psoriatic Arthritis
- Axial Spondyloarthritis
- Hidradenitis Suppurativa
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 years and older
- Sex
- Female
- Healthy volunteers
- Not accepted
- Sponsor
- UCB Biopharma SRL
- Last updated on ClinicalTrials.gov
- September 18, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Up0122 105 · Santa Monica, CA
Florida · 1
- Up0122 103 · South Miami, FL
Massachusetts · 1
- Up0122 104 · Boston, MA
North Carolina · 2
- Up0122 106 · Chapel Hill, NC
- Up0122 102 · Durham, NC
Wisconsin · 1
- Up0122 101 · Milwaukee, WI
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.